CURE Ocular Melanoma

05/15/2026

Wishing our New England ocular melanoma community including Team Aura, the best of luck tomorrow! Thank you for all you have done to support our New England ocular melanoma community. Leave a comment and wish them the best of luck. https://buff.ly/W20lE9p

05/15/2026

Today is and an opportunity to elevate awareness of ocular melanoma diagnosis and treatment and the importance of overall eye health! Founded in 2013 by Ocular Melanoma UK, the CURE OM initiative is honored to join in on this special day that demonstrates the realities of living with ocular melanoma and honors and recognizes those whose lives are affected by this rare melanoma subtype.

If you are hosting an event today or wearing an eye patch, we encourage you to share your pics and tag us!

05/13/2026

The MRF's CURE OM initiative is excited to partner with Ocular Melanoma UK for on May 15. Eye Patch Day highlights the importance of eye health and what it's like to have monocular vision. We invite the community to share your eye patch selfies and tag us using .

As a rare melanoma subtype, CURE OM seeks to improve the lives of people affected by OM. On and every day, CURE OM remains committed to providing educational support, enabling research leading to new therapeutics and clinical trials and advocating for the entire OM community.

Learn more - https://melanoma.org/cure-om/

05/12/2026

Huge thank you to our DC ocular melanoma teams including Team Cyclops and Team ImmPACT Makers for supporting our Miles for Melanoma 5K event! With your support, you helped raise over $3,278 for the ocular melanoma community! Great job and we can’t wait to see you in 2027!

05/12/2026

We are honored to share the incredible story featured in People of Ashley McCrary, patient and founder of Eye on Grace - a nonprofit dedicated to helping ocular melanoma patients afford travel for life-saving treatments! Ashely discusses the importance of eye health, her initial diagnosis and how she transformed fear and her journey into purpose, advocacy and support for others navigating this rare subtype - https://people.com/mom-discovered-rare-cancer-in-her-eye-then-decided-to-live-to-help-others-exclusive-11967748

Rare eye cancer survivor Ashley McCrary outlasted a grim prognosis and now helps hundreds of other patients pay travel expenses for their crucial care

05/12/2026

05/12/2026

The CURE OM initiative is looking for patients and caregivers living with high-risk primary or metastatic uveal melanoma to participate in a virtual closed panel discussion this June. This is a unique opportunity to share your experience and help advance understanding of the uveal melanoma journey.

Participants will receive a $150 gift card as a thank-you for their time. For more information and to participate, please reach out to us at cureom@melanoma.org by June 1.

05/11/2026

New England, don’t wait—regular rate registration closes Wednesday, May 13 at 11:59 PM ET! Join us this Saturday, May 16 at Franklin Park Zoo for an unforgettable Miles for Melanoma 5K. Be sure to join OM Team Aura or start your own team to raise funds for ocular melanoma. Secure your spot now: https://buff.ly/edydLVg

05/08/2026

Wishing our DC ocular melanoma community, including Team Cyclops and Team ImmPACT Makers, the best of luck tomorrow! Thank you for all you have done to support our DC ocular melanoma community. Onsite registration is still available for anyone who would like to join and show their support. Leave a comment and wish them the best of luck!

05/07/2026

May is Melanoma Awareness Month and Healthy Vision Month and presents us with a great opportunity to focus on the importance of early detection. While we know ocular melanoma is not preventable, early detection can save lives. Our CURE OM initiative and campaign encourages all to schedule a regular dilated eye exam and be sure to wear appropriate eyewear when outside.

Help us elevate awareness around the importance of eye health! To learn more about CURE OM and gain valulable information for the treatment, diagnosis and resources to support OM patients, visit - https://buff.ly/tSDVhYI

05/06/2026

Data presented at the American Academy of Cancer Research (AACR) on Tebentafusp (KIMMTRAK) showed almost double 5-year survival (16%) compared to 8% of physician choice of treatment. Patients lived longer overall- about 21.6 months vs. 16.9 months. This is exciting news for the metastatic OM patient community who are HLA-A*0201 positive. This is the longest survival follow-up ever reported in a randomized clinical trial for metastatic uveal melanoma:

The 5-year OS rate was 16% and 8% in the tebentafusp and control arms, respectively, for patients with HLA-A*02:01–positive uveal melanoma.